drugset / Trial / NCT00820053

A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection

NCT00820053

Phase 2 Completed 450 enrolled Eastern Hepatobiliary Surgery Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

The aim of this study is to analyze the therapeutic effect of adjuvant TACE after resection.Patients receiving curative resection (R0) were randomized to postoperative TACE group and no TACE group. The time to recurrence ,the overall survival as well as the incidence of complications after therapy was observed to confirm the role of adjuvant TACE.

Timeline

Start
2009-01
Primary completion
2009-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Epirubicin Small molecule 30 mg Other
Background lipiodol Unknown 5 ml Other